|
⚲
|
| Keyboard |
| JFL Capital Management LLC
✚
|
|
|---|---|
| CRD # | 174202 |
| SEC # | 801-110801 |
| CIK # | 0001770400, 0001687888 |
| AUM | |
| Employees | 3 (67% Investors, 0% Brokers) |
| Phone | 512-761-4500 |
| Address | 1415 Rr 620 South Lakeway, TX 78734 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | JFL Partners Fund LP | [2017-06-12] | 10.8 M | 63.0 M |
| Filed 2015-12-11 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 63.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 1 | 152.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 215.0 |
| By Discretionary | ||
| Discretionary | 3 | 215.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 215.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 13.0 | |
| United States Persons | 202.0 | |
| Total | 3 | 215.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Joseph Lawler | Executive Officer | 19 | 3 | |
| Jfl Capital Management LP | Executive Officer | 4 | 2 | |
| Jfl Capital Holdings LLC | Executive Officer | 4 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001687888] | |
| 4 | [0001687888] | |
| SC 13D | [0001687888] | |
| SC 13G | [0001687888] | |
| 3 | [0001770400] | |
| 4 | [0001770400] | |
| SC 13G | [0001770400] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.1B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 254900KN8ADSZGJS6Y34 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| JFL Capital Management LLC | |
| Lawler Joseph F | |
| JFL Partners Fund LP | |
| Merrimack Pharmaceuticals Inc | |
| JFL Capital Holdings LLC | |
| JFL Capital Management LP | |
| GYRE Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-07-02 | Buy | 7,024 | $5.85 | 41,090 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-07-02 | Buy | 10,107 | $5.85 | 59,126 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-07-01 | Buy | 5,659 | $6.00 | 33,954 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-07-01 | Buy | 3,934 | $6.00 | 23,604 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-06-28 | Buy | 13,902 | $5.95 | 82,717 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-06-28 | Buy | 9,662 | $5.95 | 57,489 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-04-08 | Buy | 6,484 | $5.73 | 37,153 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-04-08 | Buy | 4,506 | $5.73 | 25,819 |
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2019-04-05 | Buy | 26,288 | $5.95 | 156,414 |